Works matching DE "IONIS Pharmaceuticals Inc."
Results: 25
FDA Approves Ionis' Tryngolza as First Treatment for Familial Chylomicronemia Syndrome.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 14
- Publication type:
- Article
GSK's RNA splash.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 6, p. 539, doi. 10.1038/nbt0610-539b
- By:
- Publication type:
- Article
Genzyme and Isis strike megadeal.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 3, p. 251, doi. 10.1038/nbt0308-251
- By:
- Publication type:
- Article
Companies jostle for lead in RNAi, despite uncertainties.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 11, p. 1191, doi. 10.1038/nbt1107-1191
- By:
- Publication type:
- Article
News in brief.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 10, p. 1070, doi. 10.1038/nbt1007-1070
- By:
- Publication type:
- Article
Antisense—down, but not out.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 5, p. 497, doi. 10.1038/nbt0507-497
- By:
- Publication type:
- Article
A reprise for collaborative financing in biotech.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 8, p. 873, doi. 10.1038/nbt0806-873
- By:
- Publication type:
- Article
Analysts: Isis?Lilly deal validates antisense.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 10, p. 898, doi. 10.1038/nbt1001-898
- By:
- Publication type:
- Article
Isis and antisense face crucial test without Novartis.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 1, p. 19, doi. 10.1038/71852
- By:
- Publication type:
- Article
Research collaborations.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 2, p. 119, doi. 10.1038/6098
- Publication type:
- Article
Antisense drugs progressing through product pipelines.
- Published in:
- American Journal of Health-System Pharmacy, 2002, v. 59, n. 21, p. 2046, doi. 10.1093/ajhp/59.21.2046
- Publication type:
- Article
Small RNAs: Leaner, meaner siRNAs.
- Published in:
- Nature Methods, 2012, v. 9, n. 11, p. 1050, doi. 10.1038/nmeth.2240
- By:
- Publication type:
- Article
News Blast.
- Published in:
- Bio-IT World, 2006, v. 5, n. 4, p. 14
- Publication type:
- Article
News Blast.
- Published in:
- Bio-IT World, 2005, v. 4, n. 9, p. 8
- Publication type:
- Article
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 11, p. 804, doi. 10.1038/nrd3583
- Publication type:
- Article
The long march of antisense.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 401, doi. 10.1038/nrd3474
- By:
- Publication type:
- Article
Antisense Molecule against MASH from Ionis Meets Primary Endpoint in Phase 2 Trial.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
First Rounders Podcast: Stanley Crooke.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 9, p. 897, doi. 10.1038/nbt.3336
- Publication type:
- Article
Antisense battles small molecule for slice of rare lipid disorder market.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 179, doi. 10.1038/nbt0313-179
- By:
- Publication type:
- Article
Isis inks two antisense deals.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 2, p. 91, doi. 10.1038/nbt0213-91a
- By:
- Publication type:
- Article
Big players jostle for pole position in muscular dystrophy.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 10, p. 904, doi. 10.1038/nbt1012-904b
- By:
- Publication type:
- Article
Science in brief.
- Published in:
- Chemistry & Industry, 2010, n. 8, p. 7
- Publication type:
- Article
Business digest.
- Published in:
- Chemistry & Industry, 2009, n. 2, p. 13
- Publication type:
- Article
Genzyme deal.
- Published in:
- Chemistry & Industry, 2008, n. 15, p. 5
- Publication type:
- Article